鈥滃厜鍗椻濋噾鑳冮尃

Pa铆s: Taiw谩n

Idioma: chino

Fuente: 琛涚敓绂忓埄閮ㄩ鍝佽棩鐗╃鐞嗙讲 (Ministry of Health and Welfare, Food And Drug Administration)

Ingredientes activos:

DICYCLOMINE HCL;;CHLORDIAZEPOXIDE HCL;;CHLOROPHYLL SODIUM COPPER;;MAGNESIUM ALUMINUM HYDROXIDE CO-DRIED GEL;;MAGNESIUM OXIDE;;SCOPOLAMINE BROMOBUTYLATE;;ALUMINUM SILICATE

Disponible desde:

鍏夊崡瑁借棩鑲′唤鏈夐檺鍏徃瀹滆槶寤 瀹滆槶绺e疁铇競榛庢槑浜岃矾240铏 (28163834)

C贸digo ATC:

A02X

formulario farmac茅utico:

閷犲姂

Composici贸n:

DICYCLOMINE HCL (1208001810) MG; SCOPOLAMINE BROMOBUTYLATE (1208004610) MG; CHLORDIAZEPOXIDE HCL (2824200210) MG; MAGNESIUM ALUMINUM HYDROXIDE CO-DRIED GEL (5604002301) MG; MAGNESIUM OXIDE (5612001300) MG; CHLOROPHYLL SODIUM COPPER (8416000640) MG; ALUMINUM SILICATE (9600002000) (SYN.)MG

Unidades en paquete:

濉戣啝鐡惰

clase:

瑁姐鍔

tipo de receta:

闋堢敱閱斧铏曟柟浣跨敤

Fabricado por:

鍏夊崡瑁借棩鑲′唤鏈夐檺鍏徃瀹滆槶寤 瀹滆槶绺e疁铇競榛庢槑浜岃矾240铏 TW

脕rea terap茅utica:

OTHER DRUGS FOR ACID RELATED DISORDERS

indicaciones terap茅uticas:

鑳冦佸崄浜屾寚鑵告桨鐦嶃佽儍鐥涖佽儍閰搁亷澶氥佽儍鐥欐敚銆佹ャ佹參鎬ц儍鐐庛

Resumen del producto:

鏈夋晥鏃ユ湡: 2024/05/25; 鑻辨枃鍝佸悕: KING WEI TABLETS "K.N."

Fecha de autorizaci贸n:

1977-04-15